Your browser doesn't support javascript.
loading
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.
Hanna, Glenn J; Busaidy, Naifa L; Chau, Nicole G; Wirth, Lori J; Barletta, Justine A; Calles, Antonio; Haddad, Robert I; Kraft, Stefan; Cabanillas, Maria E; Rabinowits, Guilherme; O'Neill, Anne; Limaye, Sewanti A; Alexander, Erik K; Moore, Francis D; Misiwkeiwicz, Krystof; Thomas, Tom; Nehs, Matthew; Marqusee, Ellen; Lee, Stephanie L; Jänne, Pasi A; Lorch, Jochen H.
Afiliação
  • Hanna GJ; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Busaidy NL; Department of Medical Oncology/The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chau NG; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wirth LJ; Department of Medical Oncology/Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Barletta JA; Department of Pathology/Brigham & Women's Hospital, Boston, Massachusetts.
  • Calles A; Departamento de Oncología/Hospital General Universitario Gregorio Maranon, Madrid, Spain.
  • Haddad RI; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kraft S; Department of Medical Oncology/Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Cabanillas ME; Department of Medical Oncology/The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rabinowits G; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • O'Neill A; Department of Biostatistics and Computational Biology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Limaye SA; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Alexander EK; Department of Endocrinology, Diabetes and Hypertension/Brigham & Women's Hospital, Boston, Massachusetts.
  • Moore FD; Department of Surgery/Brigham & Women's Hospital, Boston, Massachusetts.
  • Misiwkeiwicz K; Department of Medical Oncology/Mount Sinai Hospital, New York, New York.
  • Thomas T; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nehs M; Department of Surgery/Brigham & Women's Hospital, Boston, Massachusetts.
  • Lee SL; Center for Hematology and Medical Oncology/Boston Medical Center, Boston, Massachusetts.
  • Jänne PA; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lorch JH; Department of Medical Oncology/Dana-Farber Cancer Institute, Boston, Massachusetts. Jochen_Lorch@dfci.harvard.edu.
Clin Cancer Res ; 24(7): 1546-1553, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29301825
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Carcinoma Anaplásico da Tireoide / Everolimo / Radioisótopos do Iodo / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Carcinoma Anaplásico da Tireoide / Everolimo / Radioisótopos do Iodo / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article